+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Forecast 2024-2030- Product Image
Global Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Forecast 2024-2030- Product Image
Sale

Global Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967551
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Theranostics Market size was estimated at USD 2.33 billion in 2023, USD 2.67 billion in 2024, and is expected to grow at a CAGR of 14.89% to reach USD 6.18 billion by 2030.

Theranostics represents an innovative field in medical science that combines diagnostics with targeted therapy based on diagnostic test results. This approach enables personalized treatment, allowing for more efficient and effective healthcare delivery by tailoring treatment to the individual's specific disease characteristics. The primary applications of theranostics include oncology, cardiovascular diseases, neurological disorders, and infectious diseases, among others. The end-users of theranostics are largely hospitals and clinics, diagnostic laboratories, and research institutions, where the integration of therapeutic and diagnostic processes can significantly enhance patient care.

The increasing prevalence of target diseases worldwide is expanding the need for theranostics. The growing inclination towards personalized medicines and rising advancements in molecular biology are expanding the usage of theranostics. Additionally, the growth of healthcare infrastructure and increasing investments in R&D activities globally serve as key drivers for the growth of the theranostics market. High costs associated with R&D and issues related to data privacy and the ethical considerations of personalized medicine pose significant challenges to market growth. Growing development of novel biomarkers, non-invasive imaging techniques, and precision therapeutics are expected to create opportunities for market growth. The integration of data analytics and machine learning presents a frontier for developing predictive models for patient response, optimizing treatment regimens, and monitoring disease progression.

Regional Insights

The Americas represents a highly developing landscape for theranostics market development, characterized by high healthcare expenditure, robust patent registrations, and significant investments in personalized medicine. Growing awareness of personalized healthcare benefits with rising public and private sector investments for research and application in theranostics are expected to create a platform for the market in the Americas. In the European Union (EU), regulatory support, along with strong healthcare systems, promotes the growth of the theranostics market. Countries including Germany, France, and the UK are at the forefront, with research centered on oncology and neurodegenerative diseases.

The Middle East shows emerging interest, propelled by investments in healthcare infrastructure and partnerships with Western biotech firms. Africa displays potential particularly in regions with developing healthcare systems, focusing on accessible diagnostic services. Asia Pacific is rapidly emerging as a significant region in the theranostics field, backed by government initiatives aimed at boosting innovation in personalized medicine. Japan's aging population drives need for advanced theranostic solutions, particularly in oncology and cardiovascular diseases. India, with its growing healthcare sector and focus on affordable care, is witnessing increased investment in localized theranostic research and collaborations.

Market Trends by Segment

  • Product: Rising usage of software for data acquisition, processing, and analysis
  • End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort

Clarity Pharmaceuticals announced the positive progression of its phase I/IIa SECuRE trial, evaluating the novel theranostic agent 64Cu/67Cu-SAR-bisPSMA in metastatic castration-resistant prostate cancer (mCRPC) patients. In the latest update, the trial's cohort 3, operating under a 3+3 study design, treated three participants with the highest dose of 12GBq of 67Cu-SAR-bisPSMA, demonstrating promising safety and efficacy outcomes. This advancement, along with continued positive outcomes, particularly under the FDA's Expanded Access Program (EAP), underscores SAR-bisPSMA's promise to improve treatment outcomes for prostate cancer patients.

BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics

GE Healthcare and BAMF Health have collaborated to accelerate the adoption of theranostic solutions across the U.S., emphasizing the importance of innovative technologies and services to enhance patient care. By integrating GE HealthCare's comprehensive solutions and BAMF Health's expertise in molecular imaging and theranostics, this partnership is poised to establish a robust framework for the deployment of precision medicine.

UCLA Health to Open Theranostics Center

UCLA Health is gearing up to launch its pioneering outpatient theranostics center later this year, marking a significant milestone in the treatment of advanced cancer. This state-of-the-art 3,000-square-foot facility situated on the Westwood campus’s 100 Medical Plaza building is designed to optimize patient care. With eight infusion chairs, the center aims to deliver up to 80 transfusions weekly, amounting to 4,000 treatment cycles annually, primarily focusing on patients with advanced prostate cancer, neuroendocrine tumors, and thyroid cancer.

Key Company Profiles

The report delves into recent significant developments in the Theranostics Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Ariceum Therapeutics GmbH, Astellas Pharma Inc., BAMF Health, Bayer AG, bioMérieux SA, Biosynth Ltd., Cardinal Health, Inc., Cerebral Therapeutics, Inc., Clarity Pharmaceuticals, Curasight A/S, Curium Inc., Evergreen Theragnostics, Inc., GE HealthCare Technologies, Inc., Hermes Medical Solutions AB, Icon Group, Indi Molecular, Inc., Integrated Clinical Oncology Network Pty Ltd., Invicro, LLC, Ipsen Pharma, Radiopharm Theranostics Limited, Ratio Therapeutics, Siemens Healthineers AG, SOFIE Co., Telix Pharmaceuticals Limited, and United Theranostics.

This research report offers invaluable insights into various crucial aspects of the Theranostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of target diseases globally
5.1.1.2. Rising advancements in personalized medicine and molecular biology
5.1.2. Restraints
5.1.2.1. High costs associated with R&D and the complexity of regulatory approvals
5.1.3. Opportunities
5.1.3.1. Increasing integration of data analytics and machine learning in theranostics
5.1.3.2. Growing development of novel biomarkers and non-invasive imaging techniques
5.1.4. Challenges
5.1.4.1. Data privacy and the ethical considerations of personalized medicine
5.2. Market Segmentation Analysis
5.2.1. Product: Rising usage of software for data acquisition, processing, and analysis
5.2.2. End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Theranostics Market, by Product
6.1. Introduction
6.2. Product
6.3. Services
6.4. Software
7. Theranostics Market, by Application
7.1. Introduction
7.2. Bone Metastatis
7.3. Cardiovascular Diseases
7.4. Lymphoma
7.5. Neuroendocrine Tumors
7.6. Prostate Cancer
8. Theranostics Market, by End-User
8.1. Introduction
8.2. Cancer Care Centers
8.3. Hospitals
8.4. Research & Academic Centers
8.5. Theranostics Centers
9. Americas Theranostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Theranostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Theranostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
12.3.2. BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics
12.3.3. UCLA Health to Open Theranostics Center
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. THERANOSTICS MARKET RESEARCH PROCESS
FIGURE 2. THERANOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THERANOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 95. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 96. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 97. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 98. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 99. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 104. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 110. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 111. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 112. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 113. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 114. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 115. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 116. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 117. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 126. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 127. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 128. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 129. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 130. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 131. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 132. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 133. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 142. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 143. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 144. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 145. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 146. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 147. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 148. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 149. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 158. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 159. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 160. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 161. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 162. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 163. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 164. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 165. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 175. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 176. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 177. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 178. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 179. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 180. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 181. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 186. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 194. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 196. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 198. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 204. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 210. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 211. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 212. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 213. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 214. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 215. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 216. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 217. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 226. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 227. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 228. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 229. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 230. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 231. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 232. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 233. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 242. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 243. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 244. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 245. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 246. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 247. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 248. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 249. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 258. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 259. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 260. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 261. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 262. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 263. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 264. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 265. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 274. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 275. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 276. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 277. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 278. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 279. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 280. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 281. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 290. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 291. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 292. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 293. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 294. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 295. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 296. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 297. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 306. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 307. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 308. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 309. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 310. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 311. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 312. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 313. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 322. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 323. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 324. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 325. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 326. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 327. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 328. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 329. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 338. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 339. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 340. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 341. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 342. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 343. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 344. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
TABLE 345. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 350. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 351. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
TABLE 354. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
TABLE 355. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
TABLE 356. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
TABLE 357. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 358. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 359. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
TABLE 360. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWAR

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • Ariceum Therapeutics GmbH
  • Astellas Pharma Inc.
  • BAMF Health
  • Bayer AG
  • bioMérieux SA
  • Biosynth Ltd.
  • Cardinal Health, Inc.
  • Cerebral Therapeutics, Inc.
  • Clarity Pharmaceuticals
  • Curasight A/S
  • Curium Inc.
  • Evergreen Theragnostics, Inc.
  • GE HealthCare Technologies, Inc.
  • Hermes Medical Solutions AB
  • Icon Group
  • Indi Molecular, Inc.
  • Integrated Clinical Oncology Network Pty Ltd.
  • Invicro, LLC
  • Ipsen Pharma
  • Radiopharm Theranostics Limited
  • Ratio Therapeutics
  • Siemens Healthineers AG
  • SOFIE Co.
  • Telix Pharmaceuticals Limited
  • United Theranostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.18 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Global Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028 - Product Image

Global Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028

  • Report
  • 194 Pages
  • Global
From
Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 239 Pages
  • Global
From
Radiopharmaceutical Theranostics Global Market Report 2024 - Product Image

Radiopharmaceutical Theranostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Theranostics Global Market Report 2024 - Product Image

Theranostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.